Status:
COMPLETED
Optimising Visual Acuity Measurement in Macular Degeneration
Lead Sponsor:
Moorfields Eye Hospital NHS Foundation Trust
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
20+ years
Brief Summary
Age-related macular degeneration (AMD) is the leading cause of visual impairment in the UK. The condition is characterised by damage to the region of the retina (macula) responsible for detailed centr...
Eligibility Criteria
Inclusion
- Group 2 - Healthy control participants:
- Inclusion criteria will include:
- Absence of ocular disease in either eye
- Male or female, aged 18 years or older
- The absence of significant media opacities
- Ability to understand nature/purpose of the study and to provide informed consent
- Ability to follow instructions and complete the study
- Ability to speak English
- Exclusion criteria will include:
- Any systemic disease likely to affect visual performance
- Presence of any ocular disease
- Hearing impairment sufficient to interfere with hearing instructions
- Poor understanding of English language and/or alphabet
- Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.
Exclusion
Key Trial Info
Start Date :
July 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04920071
Start Date
July 25 2019
End Date
May 31 2023
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Moorfields Eye Hospital NHS Foundation Trust
London, United Kingdom